Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iterum Therapeutics (ITRM) Other Non-Current Assets (2017 - 2022)

Historic Other Non-Current Assets for Iterum Therapeutics (ITRM) over the last 6 years, with Q3 2022 value amounting to $2.7 million.

  • Iterum Therapeutics' Other Non-Current Assets fell 6644.19% to $2.7 million in Q3 2022 from the same period last year, while for Sep 2022 it was $2.7 million, marking a year-over-year decrease of 6644.19%. This contributed to the annual value of $4.7 million for FY2021, which is 5631.4% down from last year.
  • Iterum Therapeutics' Other Non-Current Assets amounted to $2.7 million in Q3 2022, which was down 6644.19% from $3.1 million recorded in Q2 2022.
  • Iterum Therapeutics' 5-year Other Non-Current Assets high stood at $13.7 million for Q3 2020, and its period low was $2.7 million during Q3 2022.
  • For the 5-year period, Iterum Therapeutics' Other Non-Current Assets averaged around $8.5 million, with its median value being $9.9 million (2021).
  • In the last 5 years, Iterum Therapeutics' Other Non-Current Assets skyrocketed by 31344.85% in 2019 and then tumbled by 6691.18% in 2022.
  • Iterum Therapeutics' Other Non-Current Assets (Quarter) stood at $4.1 million in 2018, then surged by 226.06% to $13.4 million in 2019, then dropped by 20.52% to $10.7 million in 2020, then crashed by 56.31% to $4.7 million in 2021, then crashed by 42.25% to $2.7 million in 2022.
  • Its last three reported values are $2.7 million in Q3 2022, $3.1 million for Q2 2022, and $4.6 million during Q1 2022.